Table 4 Results of expression of CD68 and M-CSF in tumor versus malignancy grade in patients with soft tissue sarcomas, N = 249
From: Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
Expression | Malignancy grade (%) | Â | ||
|---|---|---|---|---|
| Â | Grade 1 | Grade 2 | Grade 3 | Total |
CD68, Low | 23 (40) | 16 (28) | 18 (32) | 57 (100) |
CD68, High | 37 (22) | 73 (42) | 62 (36) | 172 (100) |
Total | 60 (26) | 89 (39) | 80 (35) | 229 (100) |
Missing | 20 | Â | Chi-Square | 8.319 |
| Â | Â | Â | P-value | 0.016 |
| Â | Grade 1 | Grade 2 | Grade 3 | Total |
M-CSF, Low | 23 (41) | 18 (32) | 15 (27) | 56 (100) |
M-CSF, High | 35 (21) | 67 (40) | 67 (40) | 169 (100) |
Total | 58 (26) | 85 (38) | 82 (37) | 225 (100) |
Missing | 24 | Â | Chi-Square | 9.300 |
| Â | Â | Â | P-value | 0.010 |
| Â | Grade 1 | Grade 2 | Grade 3 | Total |
TGF-beta, Low | 15 (13) | 66 (56) | 36 (31) | 117 (100) |
TGF-beta, High | 6 (5) | 71 (58) | 45 (37) | 122 (100) |
Total | 21 (9) | 137 (57) | 81 (34) | 239 (100) |
Missing | 10 | Â | Chi-Square | 7.091 |
| Â | Â | Â | P-value | 0.029 |